Ap­plied Ther­a­peu­tics on part­ner­ship hunt as it seeks path for­ward af­ter PhI­II di­a­bet­ic car­diomy­opa­thy fail

Ap­plied Ther­a­peu­tics’ drug can­di­date for cer­tain di­a­bet­ic car­diomy­opa­thy pa­tients has dis­ap­point­ed in a late-stage study, al­though it showed po­ten­tial in a pre­spec­i­fied sub­set. The com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER